Drug profile · INN
prochlorperazine maleate
PROCHLORPERAZINE
prochlorperazine maleate (PROCHLORPERAZINE) is a dopamine d2 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — prochlorperazine maleate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
prochlorperazine maleate (PROCHLORPERAZINE) is a dopamine d2 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine D2 receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is prochlorperazine maleate?
prochlorperazine maleate (PROCHLORPERAZINE) is a dopamine d2 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for prochlorperazine maleate?
PROCHLORPERAZINE is a marketed brand name for prochlorperazine maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of prochlorperazine maleate?
prochlorperazine maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.